---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-052111"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2024-12-26T23:59:59+00:00"
generated_at: "2026-05-28T23:25:07.338717+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals raises up to $1.25M via Series B Preferred and warrants

## Summary
- Issued 350 shares of Series B Preferred for $350K and warrants for 462K shares at $2.57-$2.71 exercise price.
- Anticipates selling additional $900K of Series B Preferred and 1.188M warrants on similar terms.
- Warrants exercisable after 180 days, 5-year term; conversion of Preferred limited by $2.25 floor price.
- Purchasers granted 18-month participation right in future financings up to their subscription amount.

## SEC filing metadata
- accession: 0001493152-24-052111
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2024-12-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315224052111/0001493152-24-052111-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315224052111/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-052111
- JSON: https://secwatch.observer/filing/0001493152-24-052111.json
- Plain text: https://secwatch.observer/filing/0001493152-24-052111.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.